Cart
sales@molnova.com
DAPT
CAS No. 208255-80-5
DAPT ( GSI-IX )
Catalog No. M13243 CAS No. 208255-80-5
DAPT (GSI-IX) is a novel γ-secretase inhibitor, which inhibits Aβ production with IC50 of 20 nM in HEK 293 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | In Stock |
|
| 10MG | 81 | In Stock |
|
| 25MG | 151 | In Stock |
|
| 50MG | 264 | In Stock |
|
| 100MG | 393 | In Stock |
|
| 200MG | 491 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDAPT
-
NoteResearch use only, not for human use.
-
Brief DescriptionDAPT (GSI-IX) is a novel γ-secretase inhibitor, which inhibits Aβ production with IC50 of 20 nM in HEK 293 cells.
-
DescriptionDAPT (GSI-IX) is a novel γ-secretase inhibitor, which inhibits Aβ production with IC50 of 20 nM in HEK 293 cells.
-
In VitroDAPT (GMP) (9 d) induces human induced pluripotent stem cells develop into expandable myoblasts.DAPT (GMP) (13 d) induces human pluripotent stem cells (hPSCs) develop into functional neurons.
-
In Vivo——
-
SynonymsGSI-IX
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptorγ secretase(Aβ)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number208255-80-5
-
Formula Weight432.46
-
Molecular FormulaC23H26F2N2O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 50 mg/mL (115.61 mM); DMSO: 86 mg/mL (198.86 mM)
-
SMILESO=C(OC(C)(C)C)[C@H](C1=CC=CC=C1)NC([C@H](C)NC(CC2=CC(F)=CC(F)=C2)=O)=O
-
Chemical Nametert-butyl (S)-2-((S)-2-(2-(3,5-difluorophenyl)acetamido)propanamido)-2-phenylacetate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dovey HF, et al. J Neurochem. 2001, 76(1), 173-18
molnova catalog
related products
-
MRK-560
MRK-560 is an effective and brain-penetrant inhibitor of γ-secretase.
-
Jagged-1 188-204
This peptide is a fragment of the JAG-1 protein. JAG-1 is Notch ligand, a peptide that is the most conspicuously expressed ligand in skin. JAG-1 induces epidermal maturation. Exposing submerged keratinocytes monolayers to JAG-1 with elevated calcium concentration produces stratification with loricrin expression and NF-αB activation.
-
Rovalpituzumab
Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) and is utilized to synthesize antibody-active molecule conjugates (ADCs).
